

[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI
[ Thu, Mar 21st 2024
] - WOPRAI

[ Wed, Mar 20th 2024
] - WOPRAI
[ Wed, Mar 20th 2024
] - WOPRAI
[ Wed, Mar 20th 2024
] - WOPRAI
[ Wed, Mar 20th 2024
] - WOPRAI
[ Wed, Mar 20th 2024
] - WOPRAI
[ Wed, Mar 20th 2024
] - WOPRAI
[ Wed, Mar 20th 2024
] - WOPRAI
[ Wed, Mar 20th 2024
] - WOPRAI
[ Wed, Mar 20th 2024
] - WOPRAI
[ Wed, Mar 20th 2024
] - WOPRAI
[ Wed, Mar 20th 2024
] - WOPRAI
Serge Belanger Maintained (VRDN) at Strong Buy and Held Target at $30 on, Mar 20th, 2024
Serge Belanger of Needham, Maintained "Viridian Therapeutics, Inc." (VRDN) at Strong Buy and Held Target at $30 on, Mar 20th, 2024.
Serge has made no other calls on VRDN in the last 4 months.
There are 4 other peers that have a rating on VRDN. Out of the 4 peers that are also analyzing VRDN, 0 agree with Serge's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Serge
- Douglas Tsao of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $37 on, Thursday, February 29th, 2024
- Laura Chico of "Wedbush" Maintained at Buy with Increased Target to $40 on, Wednesday, February 28th, 2024
- Leland Gershell of "Oppenheimer" Maintained at Buy with Increased Target to $36 on, Tuesday, December 19th, 2023
- Gregory Renza of "RBC Capital" Reiterated at Buy and Held Target at $35 on, Thursday, December 14th, 2023
Contributing Sources